These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7744122)

  • 1. Clinical efficacy and safety profile of etodolac: focus on the elderly.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):1. PubMed ID: 7744122
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety profile of etodolac in the elderly population.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):19-22. PubMed ID: 7744124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase.
    Todesco S; Del Ross T; Marigliano V; Ariani A
    Int J Clin Pharmacol Res; 1994; 14(1):11-26. PubMed ID: 7927957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
    Veys EM
    Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose etodolac in rheumatoid arthritis: a review of early studies.
    Spencer-Green G
    J Rheumatol Suppl; 1997 Feb; 47():3-9; discussion 48-50. PubMed ID: 9035014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis.
    Chikanza IC; Clarke B; Hopkins R; MacFarlane DG; Bird H; Grahame R
    Br J Clin Pract; 1994; 48(2):67-9. PubMed ID: 8024992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH; Hsu PN
    Curr Med Res Opin; 2003; 19(4):336-41. PubMed ID: 12841927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomised, multi-centre clinical study evaluating the efficacy and tolerability of nimesulide in comparison with etodalac in patients suffering from osteoarthritis of the knee.
    Lücker PW; Pawlowski C; Friedrich I; Faiella F; Magni E
    Eur J Rheumatol Inflamm; 1994; 14(2):29-38. PubMed ID: 7744131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs.
    Budsberg SC; Johnston SA; Schwarz PD; DeCamp CE; Claxton R
    J Am Vet Med Assoc; 1999 Jan; 214(2):206-10. PubMed ID: 9926009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special considerations in the use of NSAIDs in the elderly.
    Todesco S
    Eur J Rheumatol Inflamm; 1994; 14(1):7-13. PubMed ID: 7744127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of force plate analysis to assess the analgesic effects of etodolac in horses with navicular syndrome.
    Symonds KD; MacAllister CG; Erkert RS; Payton ME
    Am J Vet Res; 2006 Apr; 67(4):557-61. PubMed ID: 16579745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of etodolac in special populations.
    Benet LZ
    Eur J Rheumatol Inflamm; 1994; 14(1):15-8. PubMed ID: 7744123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
    Neri P; Yasui H; Hideshima T; Tassone P; Raje N; Catley LP; Ishitsuka K; Blotta S; Kiziltepe T; Ocio EM; Fulciniti M; Kanekal S; Elliott GT; Munshi NC; Anderson KC
    Br J Haematol; 2006 Jul; 134(1):37-44. PubMed ID: 16803565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002).
    Klauss G; Giuliano EA; Moore CP; Stuhr CM; Martin SL; Tyler JW; Fitzgerald KE; Crawford DA
    J Am Vet Med Assoc; 2007 Feb; 230(4):541-7. PubMed ID: 17302553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of prophylactic etodolac on postendodontic pain.
    Menke ER; Jackson CR; Bagby MD; Tracy TS
    J Endod; 2000 Dec; 26(12):712-5. PubMed ID: 11471639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo.
    Shigemura K; Shirakawa T; Wada Y; Kamidono S; Fujisawa M; Gotoh A
    Urology; 2005 Dec; 66(6):1239-44. PubMed ID: 16360450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction?
    Miyajima A; Ito K; Asano T; Seta K; Ueda A; Hayakawa M
    J Urol; 2001 Sep; 166(3):1124-9. PubMed ID: 11490310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
    Mukawa K; Fujii S; Tominaga K; Yoshitake N; Abe A; Kono T; Sekikawa A; Fukui H; Ichikawa K; Tomita S; Imura J; Ono Y; Shinoda M; Hiraishi H; Fujimori T
    Oncol Rep; 2008 Feb; 19(2):393-9. PubMed ID: 18202786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.